Teva Pharma Industries Ltd ADR (TEVA) is a publicly traded drug manufacturers-specialty and generic business based in the US. In the week up to 4 October Teva Pharmaceutical Industries shares surged 14.08% to a closing position of $8.83. However, over the last 12 months, Teva Pharmaceutical Industries's share price has fallen by 4.42% from $9.73. Teva Pharmaceutical Industries is listed on the NYSE and employs 34,713 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Mobile app
Best for
Index funds
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £4.10 £825.02 total |
Capital at risk |
|
£0 | £250 | £12.98 £833.89 total |
Capital at risk |
|
£0 | No minimum | £8.21 £829.12 total |
Capital at risk |
 |
£0 | £1 | £20.16 £841.07 total |
Capital at risk |
 |
£0 | £0.01 | £0.82 £821.73 total |
Capital at risk |
 |
£9.99 per month | No minimum | £20.30 £841.21 total |
Capital at risk |
 |
£0 | £50 | £4.10 £825.02 total |
Capital at risk |
 |
£36 per year | £20 | £19.76 £840.67 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $9.3
| 1 week (2022-09-28) | 16.83% |
|---|---|
| 1 month (2022-09-02) | 5.20% |
| 3 months (2022-07-05) | 20.62% |
| 1 year (2021-10-05) | -4.42% |
|---|---|
| 2 years (2020-10-05) | 9.3 |
| 3 years (2019-10-04) | 33.43% |
| 5 years (2017-10-05) | -40.69% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Teva Pharmaceutical Industries's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.755. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Teva Pharmaceutical Industries's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Teva Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $4.2 billion (£3.7 billion).
The EBITDA is a measure of a Teva Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Teva Pharmaceutical Industries.
Teva Pharmaceutical Industries's total ESG risk: 58.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Teva Pharmaceutical Industries's overall score of 58.8 (as at 01/01/2019) is pretty weak – landing it in it in the 76th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Teva Pharmaceutical Industries is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Teva Pharmaceutical Industries's environmental score: 77.02/100
Teva Pharmaceutical Industries's environmental score of 77.02 puts it squarely in the 87th percentile of companies rated in the same sector. This could suggest that Teva Pharmaceutical Industries is a laggard in its sector in terms of its environmental impact, and exposed to a greater level of risk.
Teva Pharmaceutical Industries's social score: 47.2/100
Teva Pharmaceutical Industries's social score of 47.2 puts it squarely in the 58th percentile of companies rated in the same sector. This could suggest that Teva Pharmaceutical Industries is pretty average in terms of looking after its workforce and social impact.
Teva Pharmaceutical Industries's governance score: 65.26/100
Teva Pharmaceutical Industries's governance score puts it squarely in the 81st percentile of companies rated in the same sector. That could suggest that Teva Pharmaceutical Industries is a laggard in its sector in terms of responsible leadership, and exposed to a greater level of risk.
Teva Pharmaceutical Industries's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Teva Pharmaceutical Industries scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Teva Pharmaceutical Industries hasn't always managed to keep its nose clean.
Teva Pharma Industries Ltd ADR was last rated for ESG on: 2019-01-01.
| Total ESG score | 58.8 |
|---|---|
| Total ESG percentile | 76.26 |
| Environmental score | 77.02 |
| Environmental score percentile | 87.16 |
| Social score | 47.2 |
| Social score percentile | 58.24 |
| Governance score | 65.26 |
| Governance score percentile | 80.64 |
| Level of controversy | 3 |
| Open | $9.26 |
|---|---|
| High | $9.38 |
| Low | $9.22 |
| Close | $9.3 |
| Previous close | $9.14 |
| Change | $0.16 |
| Change % | 1.7505% |
| Volume | 7,427,562 |
| 52-week range | $6.7791 - $11.34 |
|---|---|
| 50-day moving average | $9.283 |
| 200-day moving average | $8.6132 |
| Wall St. target price | $10.5 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.557 |
We're not expecting Teva Pharmaceutical Industries to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Teva Pharmaceutical Industries's shares have ranged in value from as little as $6.7791 up to $11.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teva Pharmaceutical Industries's is 1.2693. This would suggest that Teva Pharmaceutical Industries's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
Ever wondered how to buy shares in Vallon Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Vallon Pharmaceuticals.
Ever wondered how to buy shares in Qualigen Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Qualigen.
